Fennec Pharmaceuticals (FENC) Interest Coverage Ratio Growth (1y) (2015 - 2025)
Fennec Pharmaceuticals (FENC) Interest Coverage Ratio Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn | -10.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.62% |
| Sep 30, 2025 | 93.64% |
| Jun 30, 2025 | 4.71% |
| Mar 31, 2025 | -110.27% |
| Dec 31, 2024 | 51.34% |
| Sep 30, 2024 | -327.17% |
| Jun 30, 2024 | 14.66% |
| Mar 31, 2024 | 301.26% |
| Dec 31, 2023 | 75.90% |
| Sep 30, 2023 | 97.37% |
| Jun 30, 2023 | 93.56% |
| Mar 31, 2023 | 89.20% |
| Dec 31, 2022 | 87.85% |
| Sep 30, 2022 | 40.51% |
| Jun 30, 2022 | -23.30% |
| Mar 31, 2022 | 95.03% |
| Dec 31, 2021 | -63,064.22% |
| Dec 31, 2020 | 18.92% |
| Dec 31, 2019 | -11.03% |
| Jun 30, 2015 | 76.39% |